Objective This study aims to examine the potential mechanism of Shenfu Yixin Granules on heart failure (HF) based on network pharmacology, molecular docking, and experimental verification. Methods (1) The active components of herbs in Shenfu Yixin Granules were screened and retrieved through the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) PubChem database and Swiss Target Prediction platform were used to predict targets. GeneCards and OMIM databases were used to screen HF-related targets. The intersection of active ingredient targets of Shenfu Yixin Granules and HF-related targets was performed by using Venny 2.1.0 platform to obtain common targets, which were the potential targets for anti-HF effect of Shenfu Yixin Granules. The potential targets were imported into the STRING database to construct a protein-protein interaction (PPI) network and screen the core targets of Shenfu Yixin Granules for the treatment of HF. GO functional and KEGG pathway enrichment analysis of potential targets were carried out by using DAVID database. AutoDock Vina software was used for molecular docking validation of key active ingredients and core targets. (2) SD rats were randomly allocated into sham operation group, model group, Shenfu Yixin Granules (5.28 g.kg-1) group, and positive control group (sacubitril-valsartan, 20.8 mg·kg-1), with eight rats in each group. A rat model of HF after myocardial infarction was established by ligating the left anterior descending coronary artery. The rats were subsequently administered orally with the corresponding drugs once daily for a period of four weeks. Cardiac function including left ventricular ejection fraction (LVEF) and left ventricular fraction shortening (LVFS) in rats was assessed by echocardiography. Additionally, the histopathological alterations in rat heart tissue were examined using hematoxylin-eosin (HE) staining and Masson staining. The serum levels of brain natriuretic peptide (BNP), artial natriuretic peptide (ANP), and aldosterone (ALD) were determined by enzyme-linked immunosorbent assay (ELISA). Furthermore, real-time quantitative PCR and Western Blot were employed to detect mRNA and protein expressions of CAVI、F2 and MAPKI in heart tissue. (1) A total of 210 active ingredients and 1 196 targets of Shenfu Yixin Granules, as well as 801 HF-related targets were obtained. Venny 2.1.0 platform was used to acquire 97 potential targets (common targets) of Shenfu Yixin Granules for the treatment of HF. Key active ingredients, such as quercetin, luteolin, arachidonic acid, kaempferol, and tanshinaldehyde were screened by "drugs-active ingredients-disease-targets" network analysis. The core targets including MAPK1、F2、CAV1、 EDNI and GJAI were identified through PPI network analysis. The potential targets are mainly concentrated in multiple biological processes, namely, the positive regulation of gene expression, cardiac development, and the positive regulation of MAPK cascade, and involve multi key pathways including MAPK signaling pathway, HIF-1 signaling pathway and PI3K/Akt signaling pathway etc. Good binding activities were observed between MΑΡΚΙ, CAVI, EDNI, F2 and quercetin, luteolin, kaempferol, tanshinaldehyde. as well as MAPKI, F2 and arachidonic acid. (2) Compared with sham operation group, LVEF and LVFS of rats significantly reduced (P< 0.01), heart mass index obviously increased (P < 0.05) in the model group. Myocardial tissue appears obvious pathological damage, and the degree of interstitial fibrosis was serious. The collagen volume fraction of the heart significantly increased (P < 0.01) The levels of serum BNP, ANP and ALD significantly increased (P < 0.01) The mRNA and protein expressions of CAVI、F2 and MAPK1 in heart tissue significantly increased ( P < 0.05 P< 0.01). Compared with the model group, LVEF and LVFS of rats obviously increased (P < 0.01), but the decrease in heart mass index was not significant (P > 0.05) in Shenfu Yixin Granules group and positive control group. The pathological damage in myocardial tissues was significantly improved, the degree of interstitial fibrosis was significantly reduced. The collagen volume fraction of the heart significantly decreased (P < 0.01) . The levels of serum BNP, ANP and ALD significantly decreased (P < 0.01) . The mRNA and protein expressions of CAVI、F2 and MAPKI in heart tissue significantly decreased ( P < 0.05, P < 0.01 ) . Conclusion Shenfu Yixin Granules may improve heart function and myocardial fibrosis in heart failure rats through the interaction between the active ingredients (quercetin, luteolin, arachidonic acid, kaempferol, and tanshinaldehyde) and targets (MAPK1, F2, CAV-1, and EDN1), so as to regulate MAPK signaling pathway and PI3K/Akt signaling pathway. [ABSTRACT FROM AUTHOR]